<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:chebi fb="3" ids="49957">Xenon</z:chebi> has been shown to be neuroprotective in several models of in vitro and in vivo neuronal injury </plain></SENT>
<SENT sid="1" pm="."><plain>However, its putative neuroprotective properties have not been evaluated in focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>The purpose of this study was to determine if <z:chebi fb="3" ids="49957">xenon</z:chebi> offers neuroprotection in a mouse model of middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: C57BL/6 mice underwent 60 min of middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>The animals (n = 21 per group) were randomized to receive either 70% <z:chebi fb="3" ids="49957">xenon</z:chebi> + 30% O2, 70% <z:chebi fb="0" ids="29796">N2O </z:chebi>+ 30% O2, or 35% <z:chebi fb="3" ids="49957">xenon</z:chebi> + 35% <z:chebi fb="0" ids="29796">N2O </z:chebi>+ 30% O2 </plain></SENT>
<SENT sid="5" pm="."><plain>After 24 h, functional neurologic outcome (on three independent scales: four-point, general, and focal deficit scales) and cerebral <z:mpath ids='MPATH_124'>infarct</z:mpath> size were evaluated </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: The 70% <z:chebi fb="3" ids="49957">xenon</z:chebi> + 30% O2 group showed improved functional outcome (median [interquartile range], four-point scale: 2 [2], 70% <z:chebi fb="3" ids="49957">xenon</z:chebi> + 30% O2 versus 3 [2], 70% <z:chebi fb="0" ids="29796">N2O </z:chebi>+ 30% O2, P = 0.0061; general deficit scale: 9 [6], 70% <z:chebi fb="3" ids="49957">xenon</z:chebi> + 30% O2 versus 10 [4], 70% <z:chebi fb="0" ids="29796">N2O </z:chebi>+ 30% O2, P = 0.0346) </plain></SENT>
<SENT sid="7" pm="."><plain>Total cerebral <z:mpath ids='MPATH_124'>infarct</z:mpath> volumes were reduced in the 70% <z:chebi fb="3" ids="49957">xenon</z:chebi> + 30% O2 group compared with the 70% <z:chebi fb="0" ids="29796">N2O </z:chebi>+ 30% O2 group (45 +/- 17 mm3 versus 59 +/- 11 mm3, respectively; P = 0.0009) </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: In this model of transient focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo>, <z:chebi fb="3" ids="49957">xenon</z:chebi> administration improved both functional and histologic outcome </plain></SENT>
</text></document>